Oncternal Therapeutics (ONCT) Q4 2023 Earnings

Mar 7Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-3.11
-2.12
-1.13
-0.14

Details

Expected EPS
-3.07
Actual EPS
-3.11
Surprise EPS
-0.04
Surprise Percent
-1.3%

Description

⁨Oncternal Therapeutics⁩ (⁦ONCT⁩) has reported earnings of ⁦-3.11⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts